Global And United States Remicade Biosimilar Market Insights, Forecast To 2027

1 Study Coverage
1.1 Remicade Biosimilar Product Introduction
1.2 Market by Type
1.2.1 Global Remicade Biosimilar Market Size Growth Rate by Type
1.2.2 100mg/10ml
1.2.3 500mg/50ml
1.3 Market by Application
1.3.1 Global Remicade Biosimilar Market Size Growth Rate by Application
1.3.2 Blood Disorders
1.3.3 Oncology Diseases
1.4 Study Objectives
1.5 Years Considered

2 Executive Summary
2.1 Global Remicade Biosimilar Market Size, Estimates and Forecasts
2.1.1 Global Remicade Biosimilar Revenue 2016-2027
2.1.2 Global Remicade Biosimilar Sales 2016-2027
2.2 Global Remicade Biosimilar, Market Size by Region: 2016 VS 2021 VS 2027
2.3 Remicade Biosimilar Historical Market Size by Region (2016-2021)
2.3.1 Global Remicade Biosimilar Retrospective Market Scenario in Sales by Region: 2016-2021
2.3.2 Global Remicade Biosimilar Retrospective Market Scenario in Revenue by Region: 2016-2021
2.4 Remicade Biosimilar Market Estimates and Projections by Region (2022-2027)
2.4.1 Global Remicade Biosimilar Sales Forecast by Region (2022-2027)
2.4.2 Global Remicade Biosimilar Revenue Forecast by Region (2022-2027)

3 Global Remicade Biosimilar Competitor Landscape by Players
3.1 Global Top Remicade Biosimilar Manufacturers by Sales
3.1.1 Global Remicade Biosimilar Sales by Manufacturer (2016-2021)
3.1.2 Global Remicade Biosimilar Sales Market Share by Manufacturer (2016-2021)
3.2 Global Top Remicade Biosimilar Manufacturers by Revenue
3.2.1 Key Remicade Biosimilar Manufacturers Covered: Ranking by Revenue
3.2.2 Global Remicade Biosimilar Revenue by Manufacturers (2016-2021)
3.2.3 Global Remicade Biosimilar Revenue Share by Manufacturers (2016-2021)
3.2.4 Global Remicade Biosimilar Market Concentration Ratio (CR5 and HHI) (2016-2021)
3.2.5 Global Top 10 and Top 5 Companies by Remicade Biosimilar Revenue in 2020
3.2.6 Global Remicade Biosimilar Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Global Remicade Biosimilar Price by Manufacturers
3.4 Global Remicade Biosimilar Manufacturing Base Distribution, Product Types
3.4.1 Remicade Biosimilar Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Remicade Biosimilar Product Type
3.4.3 Date of International Manufacturers Enter into Remicade Biosimilar Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type (2016-2027)
4.1 Global Remicade Biosimilar Market Size by Type (2016-2021)
4.1.1 Global Remicade Biosimilar Sales by Type (2016-2021)
4.1.2 Global Remicade Biosimilar Revenue by Type (2016-2021)
4.1.3 Remicade Biosimilar Average Selling Price (ASP) by Type (2016-2021)
4.2 Global Remicade Biosimilar Market Size Forecast by Type (2022-2027)
4.2.1 Global Remicade Biosimilar Sales Forecast by Type (2022-2027)
4.2.2 Global Remicade Biosimilar Revenue Forecast by Type (2022-2027)
4.2.3 Remicade Biosimilar Average Selling Price (ASP) Forecast by Type (2022-2027)

5 Breakdown Data by Application (2016-2027)
5.1 Global Remicade Biosimilar Market Size by Application (2016-2021)
5.1.1 Global Remicade Biosimilar Sales by Application (2016-2021)
5.1.2 Global Remicade Biosimilar Revenue by Application (2016-2021)
5.1.3 Remicade Biosimilar Price by Application (2016-2021)
5.2 Remicade Biosimilar Market Size Forecast by Application (2022-2027)
5.2.1 Global Remicade Biosimilar Sales Forecast by Application (2022-2027)
5.2.2 Global Remicade Biosimilar Revenue Forecast by Application (2022-2027)
5.2.3 Global Remicade Biosimilar Price Forecast by Application (2022-2027)

6 United States by Players, Type and Application
6.1 United States Remicade Biosimilar Market Size YoY Growth 2016-2027
6.1.1 United States Remicade Biosimilar Sales YoY Growth 2016-2027
6.1.2 United States Remicade Biosimilar Revenue YoY Growth 2016-2027
6.1.3 United States Remicade Biosimilar Market Share in Global Market 2016-2027
6.2 United States Remicade Biosimilar Market Size by Players (International and Local Players)
6.2.1 United States Top Remicade Biosimilar Players by Sales (2016-2021)
6.2.2 United States Top Remicade Biosimilar Players by Revenue (2016-2021)
6.3 United States Remicade Biosimilar Historic Market Review by Type (2016-2021)
6.3.1 United States Remicade Biosimilar Sales Market Share by Type (2016-2021)
6.3.2 United States Remicade Biosimilar Revenue Market Share by Type (2016-2021)
6.3.3 United States Remicade Biosimilar Price by Type (2016-2021)
6.4 United States Remicade Biosimilar Market Estimates and Forecasts by Type (2022-2027)
6.4.1 United States Remicade Biosimilar Sales Forecast by Type (2022-2027)
6.4.2 United States Remicade Biosimilar Revenue Forecast by Type (2022-2027)
6.4.3 United States Remicade Biosimilar Price Forecast by Type (2022-2027)
6.5 United States Remicade Biosimilar Historic Market Review by Application (2016-2021)
6.5.1 United States Remicade Biosimilar Sales Market Share by Application (2016-2021)
6.5.2 United States Remicade Biosimilar Revenue Market Share by Application (2016-2021)
6.5.3 United States Remicade Biosimilar Price by Application (2016-2021)
6.6 United States Remicade Biosimilar Market Estimates and Forecasts by Application (2022-2027)
6.6.1 United States Remicade Biosimilar Sales Forecast by Application (2022-2027)
6.6.2 United States Remicade Biosimilar Revenue Forecast by Application (2022-2027)
6.6.3 United States Remicade Biosimilar Price Forecast by Application (2022-2027)

7 North America
7.1 North America Remicade Biosimilar Market Size YoY Growth 2016-2027
7.2 North America Remicade Biosimilar Market Facts & Figures by Country
7.2.1 North America Remicade Biosimilar Sales by Country (2016-2021)
7.2.2 North America Remicade Biosimilar Revenue by Country (2016-2021)
7.2.3 United States
7.2.4 Canada

8 Asia Pacific
8.1 Asia Pacific Remicade Biosimilar Market Size YoY Growth 2016-2027
8.2 Asia Pacific Remicade Biosimilar Market Facts & Figures by Region
8.2.1 Asia Pacific Remicade Biosimilar Sales by Region (2016-2021)
8.2.2 Asia Pacific Remicade Biosimilar Revenue by Region (2016-2021)
8.2.3 China
8.2.4 Japan
8.2.5 South Korea
8.2.6 India
8.2.7 Australia
8.2.8 Australia
8.2.9 Indonesia
8.2.10 Thailand
8.2.11 Malaysia

9 Europe
9.1 Europe Remicade Biosimilar Market Size YoY Growth 2016-2027
9.2 Europe Remicade Biosimilar Market Facts & Figures by Country
9.2.1 Europe Remicade Biosimilar Sales by Country (2016-2021)
9.2.2 Europe Remicade Biosimilar Revenue by Country (2016-2021)
9.2.3 Germany
9.2.4 France
9.2.5 U.K.
9.2.6 Italy

10 Latin America
10.1 Latin America Remicade Biosimilar Market Size YoY Growth 2016-2027
10.2 Latin America Remicade Biosimilar Market Facts & Figures by Country
10.2.1 Latin America Remicade Biosimilar Sales by Country (2016-2021)
10.2.2 Latin America Remicade Biosimilar Revenue by Country (2016-2021)
10.2.3 Mexico
10.2.4 Brazil
10.2.5 Argentina

11 Middle East and Africa
11.1 Middle East and Africa Remicade Biosimilar Market Size YoY Growth 2016-2027
11.2 Middle East and Africa Remicade Biosimilar Market Facts & Figures by Country
11.2.1 Middle East and Africa Remicade Biosimilar Sales by Country (2016-2021)
11.2.2 Middle East and Africa Remicade Biosimilar Revenue by Country (2016-2021)
11.2.3 Turkey
11.2.4 Saudi Arabia
11.2.5 UAE

12 Company Profiles
12.1 Synthon Pharmaceuticals
12.1.1 Synthon Pharmaceuticals Corporation Information
12.1.2 Synthon Pharmaceuticals Description and Business Overview
12.1.3 Synthon Pharmaceuticals Remicade Biosimilar Sales, Revenue and Gross Margin (2016-2021)
12.1.4 Synthon Pharmaceuticals Remicade Biosimilar Products Offered
12.1.5 Synthon Pharmaceuticals Recent Development
12.2 LG Life Sciences
12.2.1 LG Life Sciences Corporation Information
12.2.2 LG Life Sciences Description and Business Overview
12.2.3 LG Life Sciences Remicade Biosimilar Sales, Revenue and Gross Margin (2016-2021)
12.2.4 LG Life Sciences Remicade Biosimilar Products Offered
12.2.5 LG Life Sciences Recent Development
12.3 Novartis (Sandoz)
12.3.1 Novartis (Sandoz) Corporation Information
12.3.2 Novartis (Sandoz) Description and Business Overview
12.3.3 Novartis (Sandoz) Remicade Biosimilar Sales, Revenue and Gross Margin (2016-2021)
12.3.4 Novartis (Sandoz) Remicade Biosimilar Products Offered
12.3.5 Novartis (Sandoz) Recent Development
12.4 Celltrion
12.4.1 Celltrion Corporation Information
12.4.2 Celltrion Description and Business Overview
12.4.3 Celltrion Remicade Biosimilar Sales, Revenue and Gross Margin (2016-2021)
12.4.4 Celltrion Remicade Biosimilar Products Offered
12.4.5 Celltrion Recent Development
12.5 Biocon
12.5.1 Biocon Corporation Information
12.5.2 Biocon Description and Business Overview
12.5.3 Biocon Remicade Biosimilar Sales, Revenue and Gross Margin (2016-2021)
12.5.4 Biocon Remicade Biosimilar Products Offered
12.5.5 Biocon Recent Development
12.6 Hospira
12.6.1 Hospira Corporation Information
12.6.2 Hospira Description and Business Overview
12.6.3 Hospira Remicade Biosimilar Sales, Revenue and Gross Margin (2016-2021)
12.6.4 Hospira Remicade Biosimilar Products Offered
12.6.5 Hospira Recent Development
12.7 Merck Serono (Merck Group)
12.7.1 Merck Serono (Merck Group) Corporation Information
12.7.2 Merck Serono (Merck Group) Description and Business Overview
12.7.3 Merck Serono (Merck Group) Remicade Biosimilar Sales, Revenue and Gross Margin (2016-2021)
12.7.4 Merck Serono (Merck Group) Remicade Biosimilar Products Offered
12.7.5 Merck Serono (Merck Group) Recent Development
12.8 Biogen idec Inc.
12.8.1 Biogen idec Inc. Corporation Information
12.8.2 Biogen idec Inc. Description and Business Overview
12.8.3 Biogen idec Inc. Remicade Biosimilar Sales, Revenue and Gross Margin (2016-2021)
12.8.4 Biogen idec Inc. Remicade Biosimilar Products Offered
12.8.5 Biogen idec Inc. Recent Development
12.9 Genentech (Roche Group)
12.9.1 Genentech (Roche Group) Corporation Information
12.9.2 Genentech (Roche Group) Description and Business Overview
12.9.3 Genentech (Roche Group) Remicade Biosimilar Sales, Revenue and Gross Margin (2016-2021)
12.9.4 Genentech (Roche Group) Remicade Biosimilar Products Offered
12.9.5 Genentech (Roche Group) Recent Development
12.10 Fosun Pharmaceutical
12.10.1 Fosun Pharmaceutical Corporation Information
12.10.2 Fosun Pharmaceutical Description and Business Overview
12.10.3 Fosun Pharmaceutical Remicade Biosimilar Sales, Revenue and Gross Margin (2016-2021)
12.10.4 Fosun Pharmaceutical Remicade Biosimilar Products Offered
12.10.5 Fosun Pharmaceutical Recent Development
12.11 Synthon Pharmaceuticals
12.11.1 Synthon Pharmaceuticals Corporation Information
12.11.2 Synthon Pharmaceuticals Description and Business Overview
12.11.3 Synthon Pharmaceuticals Remicade Biosimilar Sales, Revenue and Gross Margin (2016-2021)
12.11.4 Synthon Pharmaceuticals Remicade Biosimilar Products Offered
12.11.5 Synthon Pharmaceuticals Recent Development
12.12 Anke Biotechnology
12.12.1 Anke Biotechnology Corporation Information
12.12.2 Anke Biotechnology Description and Business Overview
12.12.3 Anke Biotechnology Remicade Biosimilar Sales, Revenue and Gross Margin (2016-2021)
12.12.4 Anke Biotechnology Products Offered
12.12.5 Anke Biotechnology Recent Development
12.13 Hualan Biological Engineering
12.13.1 Hualan Biological Engineering Corporation Information
12.13.2 Hualan Biological Engineering Description and Business Overview
12.13.3 Hualan Biological Engineering Remicade Biosimilar Sales, Revenue and Gross Margin (2016-2021)
12.13.4 Hualan Biological Engineering Products Offered
12.13.5 Hualan Biological Engineering Recent Development
12.14 Walvax Biotechnology
12.14.1 Walvax Biotechnology Corporation Information
12.14.2 Walvax Biotechnology Description and Business Overview
12.14.3 Walvax Biotechnology Remicade Biosimilar Sales, Revenue and Gross Margin (2016-2021)
12.14.4 Walvax Biotechnology Products Offered
12.14.5 Walvax Biotechnology Recent Development
12.15 Hisun Pharmaceutical
12.15.1 Hisun Pharmaceutical Corporation Information
12.15.2 Hisun Pharmaceutical Description and Business Overview
12.15.3 Hisun Pharmaceutical Remicade Biosimilar Sales, Revenue and Gross Margin (2016-2021)
12.15.4 Hisun Pharmaceutical Products Offered
12.15.5 Hisun Pharmaceutical Recent Development

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Remicade Biosimilar Industry Trends
13.2 Remicade Biosimilar Market Drivers
13.3 Remicade Biosimilar Market Challenges
13.4 Remicade Biosimilar Market Restraints

14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Remicade Biosimilar Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors

15 Research Findings and Conclusion

16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer

List of Tables
Table 1. Global Remicade Biosimilar Market Size Growth Rate by Type, 2016 VS 2021 VS 2027 (US$ Million)
Table 2. Major Manufacturers of 100mg/10ml
Table 3. Major Manufacturers of 500mg/50ml
Table 4. Global Remicade Biosimilar Market Size Growth Rate by Application (2021-2027) & (K Units)
Table 5. Global Remicade Biosimilar Market Size by Region (K Units) & (US$ Million), 2016 VS 2021 VS 2027
Table 6. Global Remicade Biosimilar Sales by Regions (2016-2021) & (K Units)
Table 7. Global Remicade Biosimilar Sales Market Share by Regions (2016-2021)
Table 8. Global Remicade Biosimilar Revenue by Regions (2016-2021) & (US$ Million)
Table 9. Global Remicade Biosimilar Sales Forecast by Region (2022-2027) & (K Units)
Table 10. Global Remicade Biosimilar Sales Market Share Forecast by Region (2022-2027)
Table 11. Global Remicade Biosimilar Revenue Forecast by Region (2022-2027) & (US$ Million)
Table 12. Global Remicade Biosimilar Revenue Market Share Forecast by Region (2022-2027)
Table 13. Global Remicade Biosimilar Sales by Manufacturers (2016-2021) (K Units)
Table 14. Global Remicade Biosimilar Sales Share by Manufacturers (2016-2021)
Table 15. Ranking of Global Top Remicade Biosimilar Manufacturers by Revenue (US$ Million) in 2020
Table 16. Remicade Biosimilar Revenue by Manufacturers (2016-2021) (US$ Million)
Table 17. Remicade Biosimilar Revenue Share by Manufacturers (2016-2021)
Table 18. Global Remicade Biosimilar Manufacturers Market Concentration Ratio (CR5 and HHI) & (2016-2021)
Table 19. Global Remicade Biosimilar by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Remicade Biosimilar as of 2020)
Table 20. Key Manufacturers Remicade Biosimilar Price (2016-2021) (US$/Unit)
Table 21. Remicade Biosimilar Manufacturers Manufacturing Base Distribution and Headquarters
Table 22. Manufacturers Remicade Biosimilar Product Type
Table 23. Date of International Manufacturers Enter into Remicade Biosimilar Market
Table 24. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 25. Global Remicade Biosimilar Sales by Type (2016-2021) (K Units)
Table 26. Global Remicade Biosimilar Sales Share by Type (2016-2021)
Table 27. Global Remicade Biosimilar Revenue by Type (2016-2021) (US$ Million)
Table 28. Global Remicade Biosimilar Revenue Share by Type (2016-2021)
Table 29. Remicade Biosimilar Average Selling Price (ASP) by Type (2016-2021) & (US$/Unit)
Table 30. Global Remicade Biosimilar Sales Forecast by Type (2022-2027) & (K Units)
Table 31. Global Remicade Biosimilar Sales Market Share Forecast by Type (2022-2027)
Table 32. Global Remicade Biosimilar Revenue Forecast V (2022-2027) & (US$ Million)
Table 33. Global Remicade Biosimilar Revenue Market Share Forecast by Type (2022-2027)
Table 34. Global Remicade Biosimilar Average Selling Price (ASP) Forecast by Type (2022-2027) & (US$/Unit)
Table 35. Global Remicade Biosimilar Sales by Application (2016-2021) (K Units)
Table 36. Global Remicade Biosimilar Sales Share by Application (2016-2021)
Table 37. Global Remicade Biosimilar Revenue by Application (2016-2021) (US$ Million)
Table 38. Global Remicade Biosimilar Revenue Share by Application (2016-2021)
Table 39. Remicade Biosimilar Average Selling Price (ASP) by Application (2016-2021) & (US$/Unit)
Table 40. Global Remicade Biosimilar Sales Forecast by Application (2022-2027) & (K Units)
Table 41. Global Remicade Biosimilar Sales Market Share Forecast by Application (2022-2027)
Table 42. Global Remicade Biosimilar Revenue Forecast by Application (2022-2027) & (US$ Million)
Table 43. Global Remicade Biosimilar Revenue Market Share Forecast by Application (2022-2027)
Table 44. Global Remicade Biosimilar Average Selling Price (ASP) Forecast by Application (2022-2027) & (US$/Unit)
Table 45. United States Remicade Biosimilar Sales (K Units) of Key Companies (2016-2021)
Table 46. United States Remicade Biosimilar Sales Share by Company (2016-2021)
Table 47. United States Remicade Biosimilar Revenue (US$ Million) by Company (2016-2021)
Table 48. United States Remicade Biosimilar Revenue Share by Company (2016-2021)
Table 49. United States Remicade Biosimilar Sales (K Units) by Type (2016-2021)
Table 50. United States Remicade Biosimilar Sales Share by Type (2016-2021)
Table 51. United States Remicade Biosimilar Revenue (US$ Million) Market Share by Type (2016-2021)
Table 52. United States Remicade Biosimilar Price (US$/Unit) by Type (2016-2021)
Table 53. United States Remicade Biosimilar Sales (K Units) by Type (2022-2027)
Table 54. United States Remicade Biosimilar Sales Share by Type (2022-2027)
Table 55. United States Remicade Biosimilar Revenue (US$ Million) Market Share by Type (2022-2027)
Table 56. United States Remicade Biosimilar Revenue Share by Type (2022-2027)
Table 57. United States Remicade Biosimilar Price (US$/Unit) by Type (2022-2027)
Table 58. United States Remicade Biosimilar Sales (K Units) by Application (2016-2021)
Table 59. United States Remicade Biosimilar Sales Share by Application (2016-2021)
Table 60. United States Remicade Biosimilar Revenue (US$ Million) Market Share by Application (2016-2021)
Table 61. United States Remicade Biosimilar Price (US$/Unit) by Application (2016-2021)
Table 62. United States Remicade Biosimilar Sales (K Units) by Application (2022-2027)
Table 63. United States Remicade Biosimilar Sales Share by Application (2022-2027)
Table 64. United States Remicade Biosimilar Revenue (US$ Million) Market Share by Application (2022-2027)
Table 65. United States Remicade Biosimilar Revenue Share by Application (2022-2027)
Table 66. United States Remicade Biosimilar Price (US$/Unit) by Application (2022-2027)
Table 67. North America Remicade Biosimilar Sales by Country (2016-2021) & (K Units)
Table 68. North America Remicade Biosimilar Sales Market Share by Country (2016-2021)
Table 69. North America Remicade Biosimilar Revenue by Country (2016-2021) & (US$ Million)
Table 70. North America Remicade Biosimilar Revenue Market Share by Country (2016-2021)
Table 71. Asia Pacific Remicade Biosimilar Sales by Region (2016-2021) & (K Units)
Table 72. Asia Pacific Remicade Biosimilar Sales Market Share by Region (2016-2021)
Table 73. Asia Pacific Remicade Biosimilar Revenue by Region (2016-2021) & (US$ Million)
Table 74. Asia Pacific Remicade Biosimilar Revenue Market Share by Region (2016-2021)
Table 75. Europe Remicade Biosimilar Sales by Country (2016-2021) & (K Units)
Table 76. Europe Remicade Biosimilar Sales Market Share by Country (2016-2021)
Table 77. Europe Remicade Biosimilar Revenue by Country (2016-2021) & (US$ Million)
Table 78. Europe Remicade Biosimilar Revenue Market Share by Country (2016-2021)
Table 79. Latin America Remicade Biosimilar Sales by Country (2016-2021) & (K Units)
Table 80. Latin America Remicade Biosimilar Sales Market Share by Country (2016-2021)
Table 81. Latin Americaa Remicade Biosimilar Revenue by Country (2016-2021) & (US$ Million)
Table 82. Latin America Remicade Biosimilar Revenue Market Share by Country (2016-2021)
Table 83. Middle East and Africa Remicade Biosimilar Sales by Country (2016-2021) & (K Units)
Table 84. Middle East and Africa Remicade Biosimilar Sales Market Share by Country (2016-2021)
Table 85. Middle East and Africa Remicade Biosimilar Revenue by Country (2016-2021) & (US$ Million)
Table 86. Middle East and Africa Remicade Biosimilar Revenue Market Share by Country (2016-2021)
Table 87. Synthon Pharmaceuticals Corporation Information
Table 88. Synthon Pharmaceuticals Description and Business Overview
Table 89. Synthon Pharmaceuticals Remicade Biosimilar Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 90. Synthon Pharmaceuticals Remicade Biosimilar Product
Table 91. Synthon Pharmaceuticals Recent Development
Table 92. LG Life Sciences Corporation Information
Table 93. LG Life Sciences Description and Business Overview
Table 94. LG Life Sciences Remicade Biosimilar Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 95. LG Life Sciences Product
Table 96. LG Life Sciences Recent Development
Table 97. Novartis (Sandoz) Corporation Information
Table 98. Novartis (Sandoz) Description and Business Overview
Table 99. Novartis (Sandoz) Remicade Biosimilar Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 100. Novartis (Sandoz) Product
Table 101. Novartis (Sandoz) Recent Development
Table 102. Celltrion Corporation Information
Table 103. Celltrion Description and Business Overview
Table 104. Celltrion Remicade Biosimilar Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 105. Celltrion Product
Table 106. Celltrion Recent Development
Table 107. Biocon Corporation Information
Table 108. Biocon Description and Business Overview
Table 109. Biocon Remicade Biosimilar Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 110. Biocon Product
Table 111. Biocon Recent Development
Table 112. Hospira Corporation Information
Table 113. Hospira Description and Business Overview
Table 114. Hospira Remicade Biosimilar Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 115. Hospira Product
Table 116. Hospira Recent Development
Table 117. Merck Serono (Merck Group) Corporation Information
Table 118. Merck Serono (Merck Group) Description and Business Overview
Table 119. Merck Serono (Merck Group) Remicade Biosimilar Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 120. Merck Serono (Merck Group) Product
Table 121. Merck Serono (Merck Group) Recent Development
Table 122. Biogen idec Inc. Corporation Information
Table 123. Biogen idec Inc. Description and Business Overview
Table 124. Biogen idec Inc. Remicade Biosimilar Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 125. Biogen idec Inc. Product
Table 126. Biogen idec Inc. Recent Development
Table 127. Genentech (Roche Group) Corporation Information
Table 128. Genentech (Roche Group) Description and Business Overview
Table 129. Genentech (Roche Group) Remicade Biosimilar Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 130. Genentech (Roche Group) Product
Table 131. Genentech (Roche Group) Recent Development
Table 132. Fosun Pharmaceutical Corporation Information
Table 133. Fosun Pharmaceutical Description and Business Overview
Table 134. Fosun Pharmaceutical Remicade Biosimilar Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 135. Fosun Pharmaceutical Product
Table 136. Fosun Pharmaceutical Recent Development
Table 137. Livzon Pharmaceutical Corporation Information
Table 138. Livzon Pharmaceutical Description and Business Overview
Table 139. Livzon Pharmaceutical Remicade Biosimilar Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 140. Livzon Pharmaceutical Product
Table 141. Livzon Pharmaceutical Recent Development
Table 142. Anke Biotechnology Corporation Information
Table 143. Anke Biotechnology Description and Business Overview
Table 144. Anke Biotechnology Remicade Biosimilar Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 145. Anke Biotechnology Product
Table 146. Anke Biotechnology Recent Development
Table 147. Hualan Biological Engineering Corporation Information
Table 148. Hualan Biological Engineering Description and Business Overview
Table 149. Hualan Biological Engineering Remicade Biosimilar Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 150. Hualan Biological Engineering Product
Table 151. Hualan Biological Engineering Recent Development
Table 152. Walvax Biotechnology Corporation Information
Table 153. Walvax Biotechnology Description and Business Overview
Table 154. Walvax Biotechnology Remicade Biosimilar Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 155. Walvax Biotechnology Product
Table 156. Walvax Biotechnology Recent Development
Table 157. Hisun Pharmaceutical Corporation Information
Table 158. Hisun Pharmaceutical Description and Business Overview
Table 159. Hisun Pharmaceutical Remicade Biosimilar Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 160. Hisun Pharmaceutical Product
Table 161. Hisun Pharmaceutical Recent Development
Table 162. Remicade Biosimilar Market Trends
Table 163. Remicade Biosimilar Market Drivers
Table 164. Remicade Biosimilar Market Challenges
Table 165. Remicade Biosimilar Market Restraints
Table 166. Remicade Biosimilar Customers List
Table 167. Remicade Biosimilar Distributors List
Table 168. Research Programs/Design for This Report
Table 169. Key Data Information from Secondary Sources
Table 170. Key Data Information from Primary Sources
List of Figures
Figure 1. Remicade Biosimilar Product Picture
Figure 2. Global Remicade Biosimilar Sales Market Share by Type in 2020 & 2027
Figure 3. 100mg/10ml Product Picture
Figure 4. 500mg/50ml Product Picture
Figure 5. Global Remicade Biosimilar Sales Market Share by Application in 2020 & 2027
Figure 6. Blood Disorders
Figure 7. Oncology Diseases
Figure 8. Remicade Biosimilar Report Years Considered
Figure 9. Global Remicade Biosimilar Market Size, (US$ Million), 2016 VS 2021 VS 2027
Figure 10. Global Remicade Biosimilar Market Size 2016-2027 (US$ Million)
Figure 11. Global Remicade Biosimilar Sales 2016-2027 (K Units)
Figure 12. Global Remicade Biosimilar Market Size Market Share by Region: 2021 Versus 2027
Figure 13. Global Remicade Biosimilar Sales Market Share by Region (2016-2021)
Figure 14. Global Remicade Biosimilar Sales Market Share by Region in 2020
Figure 15. Global Remicade Biosimilar Revenue Market Share by Region (2016-2021)
Figure 16. Global Remicade Biosimilar Revenue Market Share by Region in 2020
Figure 17. Global Remicade Biosimilar Sales Share by Manufacturer in 2020
Figure 18. The Top 10 and 5 Players Market Share by Remicade Biosimilar Revenue in 2020
Figure 19. Remicade Biosimilar Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2020
Figure 20. Global Remicade Biosimilar Sales Market Share by Type (2016-2021)
Figure 21. Global Remicade Biosimilar Sales Market Share by Type in 2020
Figure 22. Global Remicade Biosimilar Revenue Market Share by Type (2016-2021)
Figure 23. Global Remicade Biosimilar Revenue Market Share by Type in 2020
Figure 24. Global Remicade Biosimilar Sales Market Share by Application (2016-2021)
Figure 25. Global Remicade Biosimilar Sales Market Share by Application in 2020
Figure 26. Global Remicade Biosimilar Revenue Market Share by Application (2016-2021)
Figure 27. Global Remicade Biosimilar Revenue Market Share by Application in 2020
Figure 28. United States Remicade Biosimilar Sales Growth Rate 2016-2027 (K Units)
Figure 29. United States Remicade Biosimilar Revenue Growth Rate 2016-2027 (US$ Million)
Figure 30. United States Remicade Biosimilar Market Share in Global Market 2016-2027
Figure 31. United States 5 and 10 Largest Remicade Biosimilar Players Market Share by Revenue in Remicade Biosimilar in 2020
Figure 32. United States Remicade Biosimilar Revenue Share by Type (2016-2021)
Figure 33. United States Remicade Biosimilar Revenue Growth Rate by Type in 2016 & 2020
Figure 34. United States Remicade Biosimilar Revenue Share by Application (2016-2021)
Figure 35. United States Remicade Biosimilar Revenue Growth Rate by Application in 2016 & 2020
Figure 36. North America Remicade Biosimilar Sales Growth Rate 2016-2021 (K Units)
Figure 37. North America Remicade Biosimilar Revenue Growth Rate 2016-2021 (US$ Million)
Figure 38. North America Remicade Biosimilar Sales Market Share by Country in 2020
Figure 39. North America Remicade Biosimilar Revenue Market Share by Country in 2020
Figure 40. United States Remicade Biosimilar Sales Growth Rate (2016-2021) (K Units)
Figure 41. United States Remicade Biosimilar Revenue Growth Rate (2016-2021) (US$ Million)
Figure 42. Canada Remicade Biosimilar Sales Growth Rate (2016-2021) (K Units)
Figure 43. Canada Remicade Biosimilar Revenue Growth Rate (2016-2021) (US$ Million)
Figure 44. Europe Remicade Biosimilar Sales Growth Rate 2016-2021 (K Units)
Figure 45. Europe Remicade Biosimilar Revenue Growth Rate 2016-2021 (US$ Million)
Figure 46. Europe Remicade Biosimilar Sales Market Share by Country in 2020
Figure 47. Europe Remicade Biosimilar Revenue Market Share by Country in 2020
Figure 48. Germany Remicade Biosimilar Sales Growth Rate (2016-2021) (K Units)
Figure 49. Germany Remicade Biosimilar Revenue Growth Rate (2016-2021) (US$ Million)
Figure 50. France Remicade Biosimilar Sales Growth Rate (2016-2021) (K Units)
Figure 51. France Remicade Biosimilar Revenue Growth Rate (2016-2021) (US$ Million)
Figure 52. U.K. Remicade Biosimilar Sales Growth Rate (2016-2021) (K Units)
Figure 53. U.K. Remicade Biosimilar Revenue Growth Rate (2016-2021) (US$ Million)
Figure 54. Italy Remicade Biosimilar Sales Growth Rate (2016-2021) (K Units)
Figure 55. Italy Remicade Biosimilar Revenue Growth Rate (2016-2021) (US$ Million)
Figure 56. Russia Remicade Biosimilar Sales Growth Rate (2016-2021) (K Units)
Figure 57. Russia Remicade Biosimilar Revenue Growth Rate (2016-2021) (US$ Million)
Figure 58. Asia Pacific Remicade Biosimilar Sales Growth Rate 2016-2021 (K Units)
Figure 59. Asia Pacific Remicade Biosimilar Revenue Growth Rate 2016-2021 (US$ Million)
Figure 60. Asia Pacific Remicade Biosimilar Sales Market Share by Region in 2020
Figure 61. Asia Pacific Remicade Biosimilar Revenue Market Share by Region in 2020
Figure 62. China Remicade Biosimilar Sales Growth Rate (2016-2021) (K Units)
Figure 63. China Remicade Biosimilar Revenue Growth Rate (2016-2021) (US$ Million)
Figure 64. Japan Remicade Biosimilar Sales Growth Rate (2016-2021) (K Units)
Figure 65. Japan Remicade Biosimilar Revenue Growth Rate (2016-2021) (US$ Million)
Figure 66. South Korea Remicade Biosimilar Sales Growth Rate (2016-2021) (K Units)
Figure 67. South Korea Remicade Biosimilar Revenue Growth Rate (2016-2021) (US$ Million)
Figure 68. India Remicade Biosimilar Sales Growth Rate (2016-2021) (K Units)
Figure 69. India Remicade Biosimilar Revenue Growth Rate (2016-2021) (US$ Million)
Figure 70. Australia Remicade Biosimilar Sales Growth Rate (2016-2021) (K Units)
Figure 71. Australia Remicade Biosimilar Revenue Growth Rate (2016-2021) (US$ Million)
Figure 72. China Taiwan Remicade Biosimilar Sales Growth Rate (2016-2021) (K Units)
Figure 73. China Taiwan Remicade Biosimilar Revenue Growth Rate (2016-2021) (US$ Million)
Figure 74. Indonesia Remicade Biosimilar Sales Growth Rate (2016-2021) (K Units)
Figure 75. Indonesia Remicade Biosimilar Revenue Growth Rate (2016-2021) (US$ Million)
Figure 76. Thailand Remicade Biosimilar Sales Growth Rate (2016-2021) (K Units)
Figure 77. Thailand Remicade Biosimilar Revenue Growth Rate (2016-2021) (US$ Million)
Figure 78. Malaysia Remicade Biosimilar Sales Growth Rate (2016-2021) (K Units)
Figure 79. Malaysia Remicade Biosimilar Revenue Growth Rate (2016-2021) (US$ Million)
Figure 80. Latin America Remicade Biosimilar Sales Growth Rate 2016-2021 (K Units)
Figure 81. Latin America Remicade Biosimilar Revenue Growth Rate 2016-2021 (US$ Million)
Figure 82. Latin America Remicade Biosimilar Sales Market Share by Country in 2020
Figure 83. Latin America Remicade Biosimilar Revenue Market Share by Country in 2020
Figure 84. Mexico Remicade Biosimilar Sales Growth Rate (2016-2021) (K Units)
Figure 85. Mexico Remicade Biosimilar Revenue Growth Rate (2016-2021) (US$ Million)
Figure 86. Brazil Remicade Biosimilar Sales Growth Rate (2016-2021) (K Units)
Figure 87. Brazil Remicade Biosimilar Revenue Growth Rate (2016-2021) (US$ Million)
Figure 88. Argentina Remicade Biosimilar Sales Growth Rate (2016-2021) (K Units)
Figure 89. Argentina Remicade Biosimilar Revenue Growth Rate (2016-2021) (US$ Million)
Figure 90. Middle East and Africa Remicade Biosimilar Sales Growth Rate 2016-2021 (K Units)
Figure 91. Middle East and Africa Remicade Biosimilar Revenue Growth Rate 2016-2021 (US$ Million)
Figure 92. Middle East and Africa Remicade Biosimilar Sales Market Share by Country in 2020
Figure 93. Middle East and Africa Remicade Biosimilar Revenue Market Share by Country in 2020
Figure 94. Turkey Remicade Biosimilar Sales Growth Rate (2016-2021) (K Units)
Figure 95. Turkey Remicade Biosimilar Revenue Growth Rate (2016-2021) (US$ Million)
Figure 96. Saudi Arabia Remicade Biosimilar Sales Growth Rate (2016-2021) (K Units)
Figure 97. Saudi Arabia Remicade Biosimilar Revenue Growth Rate (2016-2021) (US$ Million)
Figure 98. UAE Remicade Biosimilar Sales Growth Rate (2016-2021) (K Units)
Figure 99. UAE Remicade Biosimilar Revenue Growth Rate (2016-2021) (US$ Million)
Figure 100. Remicade Biosimilar Value Chain
Figure 101. Channels of Distribution
Figure 102. Distributors Profiles
Figure 103. Bottom-up and Top-down Approaches for This Report
Figure 104. Data Triangulation
Figure 105. Key Executives Interviewed

SECONDARY RESEARCH
Secondary Research Information is collected from a number of publicly available as well as paid databases. Public sources involve publications by different associations and governments, annual reports and statements of companies, white papers and research publications by recognized industry experts and renowned academia etc. Paid data sources include third party authentic industry databases.

PRIMARY RESEARCH
Once data collection is done through secondary research, primary interviews are conducted with different stakeholders across the value chain like manufacturers, distributors, ingredient/input suppliers, end customers and other key opinion leaders of the industry. Primary research is used both to validate the data points obtained from secondary research and to fill in the data gaps after secondary research.

MARKET ENGINEERING
The market engineering phase involves analyzing the data collected, market breakdown and forecasting. Macroeconomic indicators and bottom-up and top-down approaches are used to arrive at a complete set of data points that give way to valuable qualitative and quantitative insights. Each data point is verified by the process of data triangulation to validate the numbers and arrive at close estimates.

EXPERT VALIDATION
The market engineered data is verified and validated by a number of experts, both in-house and external.

REPORT WRITING/ PRESENTATION
After the data is curated by the mentioned highly sophisticated process, the analysts begin to write the report. Garnering insights from data and forecasts, insights are drawn to visualize the entire ecosystem in a single report.